Nevro's HFX iQ spinal cord stimulator earned the European Union's CE mark, the company said Nov. 12.
Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the ...
GOTHENBURG, SWEDEN / ACCESSWIRE / November 13, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, November ...
Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good day everyone and welcome to today’s Avadel Pharmaceuticals ...
Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good afternoon, and thank you for standing by. At this time, I’d ...
Paulick Report on MSN14h
Can Vibration Plates Help With Equine Back Pain? The Answer May Not Be What You ThinkA frequency of 40 Hz, amplitude of 0.8 mm, and an acceleration of 4.9 m/s2 with a vertical type vibration was used. Results ...
Intravascular Ultrasound (IVUS): IVUS uses high-frequency sound waves to create cross-sectional ... Additionally, patients ...
Phase 3 epilepsy program advancing with X-TOLE2 topline FOS data anticipated in H2 2025– Long-term azetukalner results from X-TOLE open-label ...
Featured here, the Balance Sheet for Korro Bio Inc, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 10 period ending ...
The primary efficacy endpoint is the MPC in monthly PGTCS frequency from baseline through the DBP of ... and delivering life-changing therapeutics. We are advancing an ion channel product portfolio to ...
Reported positive YTD 2024 Adjusted EBITDA of $1.4 million Company expects Q4 2024 Net Revenue in the range of $37 million - $43 million ZYNRELEF® (bupivacaine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback